Dr. Eric Benjamin Trestman, MD

Dr. Trestman practices at Vital Heart & Vein Ambulatory Surgery Center - Humble (Hwy 59 N) in Humble, Texas.

Dr. Trestman's NPI, 1639412018, was assigned on April 3, 2013. Dr. Trestman graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2013. Dr. Trestman holds Texas license S7572.

Dr. Trestman's primary practice is Vital Heart & Vein Ambulatory Surgery Center - Humble (Hwy 59 N), at 18450 Highway 59 N, Ste 101-B, Humble, TX 77338. The practice phone is (281) 572-0050.

Dr. Trestman's primary practice is Vital Heart & Vein Ambulatory Surgery Center - Humble (Hwy 59 N) in Humble, Texas. Dr. Trestman is also affiliated with Townsen Memorial Hospital. The medical group on file is Vital Heart & Vein. Dmand AI also links Dr. Trestman to 3 more hospitals, 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trestman practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Trestman's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Trestman is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Trestman's licenses on file in 2 states: Texas and New York.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Trestman treats.

CMS data shows 952 Medicare services from Dr. Trestman across 17 procedure codes in 2024, for 247 Medicare patients. Medicare paid $71,214 for them.

CMS counts 247 Medicare patients who saw Dr. Trestman in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trestman's median patient age at 71, with 49% women.

In 2024, Dr. Trestman wrote 347 Medicare Part D claims for 104 patients. 72% of them were for generic drugs. CMS names the drug for 278 of them, across 4 drugs with 11 or more claims each, at $61,570 in total drug cost. In 2023, CMS named 134 claims across 4 drugs.

Dr. Trestman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of leg revascularization (restoring blood flow) by Dr. Trestman, more than 84% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Trestman, published from 2015 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Blood Vessel Prosthesis Implantation, Aortic Aneurysm, Abdominal and Blood Vessel Prosthesis. Dr. Trestman has published most often in Vascular. Dr. Trestman's most frequent co-authors are Evan C. Lipsitz, MD, John Phair, MD and Edvard Skripochnik, MD.

Dmand AI links Dr. Trestman to 1 clinical trial. Conditions studied include May-Thurner Syndrome and Vascular Malformations.

CMS Open Payments shows 720 general payments to Dr. Trestman from 62 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Boston Scientific Corporation paid the most, $40,949.

Dr. Trestman graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2013. Dr. Trestman is a member of SVS.

Dr. Trestman is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.